Gastrointestinal Clinical Trials
Narrow List by Age:
(Refer to Clinical Summary for age requirements)
Gastrointestinal
| Protocol | SWOG S2417CD |
|---|---|
| Cancer Type: | Colorectal CCDR |
| Fast Facts |
S2417CD, “A Pragmatic Randomized Controlled Trial to Evaluate the Effectiveness of an Intervention called Current Together After Cancer (CTAC) to Promote Guideline-Concordant Colorectal Cancer Surveillance”
Please check out the rare protocol list to locate other studies within this disease site.
| Protocol | EA2234 |
|---|---|
| Cancer Type: | Gastric Carcinomatosis |
| Fast Facts |
EA2324: A Randomized Phase II/III Trial of Intraperitoneal Paclitaxel Plus Systemic Treatment vs Systemic Treatment Alone in Gastric Carcinomatosis – STOPGAP II
Please check out the rare protocol list to locate other studies within this disease site.
| Protocol | NRG GI011 |
|---|---|
| Cancer Type: | Pancreatic |
| Fast Facts |
NRG-GI011: A PHASE III RANDOMIZED TRIAL OF DOSE ESCALATED RADIATION IN LOCALLY ADVANCED PANCREAS CANCER (LAPC) PATIENTS
Please check out the rare protocol list to locate other studies within this disease site.
Cancer clinical trials are research studies for developing better ways of detecting,
treating, and eventually preventing cancer. By taking part in a clinical trial,
you are among the first to receive new research treatments before they are widely
available. Your participation in a clinical trial will influence the future direction
of cancer care.
If you are interested in participating in a clinical trial, consult with your physician.
Please note: clinical trials are not risk free. Patients must explore the options
that are best for their individuals needs with the help of their physician.
